Abiopharma

🔍 Soares Karen (Executive)

Company: CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 382,522 shares of Class A Common Stock (Direct)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,582,583.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of April 1, 2026, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of April 1, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on April 1, 2030.